ADAP
$5.35
Adaptimmune Ther ADR
$.02
.38%
ADAP
Earnings Whisper ®
N/A
3rd Quarter September 2021
Consensus:  $0.05
Revenue:  $1.20 Mil
Monday
Nov 8
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ADAP reports earnings?
Beat
Meet
Miss

Where is ADAP's stock price going from here?
Up
Flat
Down
Stock chart of ADAP
Analysts
Summary of analysts' recommendations for ADAP
Score
Grade
Pivots
Resistance
$5.72
$5.61
$5.47

$5.36

Support
$5.22
$5.11
$4.97
Tweet
Growth
Description
Adaptimmune Therapeutics plc is a biopharmaceutical company. The Company is focused on cancer immunotherapy products based on T-cell receptor platform. Adaptimmune Therapeutics plc is based in Abingdon, United Kingdom.